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Résumé en
anglais
Schimke immunoosseous dysplasia (SIOD) is an autosomal recessive multisystem
disorder characterized by prominent spondyloepiphyseal dysplasia, T cell deficiency,
and focal segmental glomerulosclerosis. Biallelic mutations in swi/snf-related,
matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1
(SMARCAL1) are the only identified cause of SIOD, but approximately half of
patients referred for molecular studies do not have detectable mutations in
SMARCAL1. We hypothesized that skeletal features distinguish between those with
or without SMARCAL1 mutations. Therefore, we analyzed the skeletal radiographs of
22 patients with and 11 without detectable SMARCAL1 mutations. We found that
patients with SMARCAL1 mutations have a spondyloepiphyseal dysplasia (SED)
essentially limited to the spine, pelvis, capital femoral epiphyses, and possibly the
sella turcica, whereas the hands and other long bones are basically normal.
Additionally, we found that several of the adolescent and young adult patients
developed osteoporosis and coxarthrosis. Of the 11 patients without detectable
SMARCAL1 mutations, seven had a SED indistinguishable from patients with
SMARCAL1 mutations. We conclude therefore that SED is a feature of patients with
SMARCAL1 mutations and that skeletal features do not distinguish who of those with
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